Alignment Healthcare, Inc. - Common Stock, par value $0.001 per share (the "Shares") (ALHC)

Historical Holders from Q1 2021 to Q3 2025

Symbol
ALHC on Nasdaq
CUSIP
01625V104
Type / Class
Equity / Common Stock, par value $0.001 per share (the "Shares")
Shares outstanding
198M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
184M
Holdings value
$3.21B
% of all portfolios
0.006%
Grand Portfolio weight change
0%
Number of holders
230
Number of buys
143
Number of sells
-105
Average Value change %
0%
Average buys %
+0.002%
Average sells %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Alignment Healthcare, Inc. - Common Stock, par value $0.001 per share (the "Shares") (ALHC)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
GENERAL ATLANTIC, L.P. 12.3% -45% $366M -$297M 24.3M -44.8% General Atlantic, L.P. Sep 17, 2025
VANGUARD GROUP INC 6.72% $205M 13.3M The Vanguard Group Jun 30, 2025
Qatar Investment Authority 6.69% $199M 13.2M Qatar Investment Authority Sep 17, 2025
T. Rowe Price Investment Management, Inc. 6.2% $186M 12.3M T. Rowe Price Investment Management, Inc. Jun 30, 2025
WELLINGTON MANAGEMENT GROUP LLP 5.6% $194M 11.1M Wellington Management Group LLP Sep 30, 2025
BlackRock, Inc. 5.4% $188M 10.8M BlackRock, Inc. Sep 30, 2025
FMR LLC 4.2% -25% $145M -$51.8M 8.31M -26.3% FMR LLC Sep 30, 2025
Flynn James E 3.81% $144M 7.3M Deerfield Mgmt, L.P. Dec 31, 2024
CITADEL ADVISORS LLC 3.4% -38% $117M -$66.1M 6.72M -36.1% Kenneth Griffin Sep 30, 2025

Institutional Holders of Alignment Healthcare, Inc. - Common Stock, par value $0.001 per share (the "Shares") (ALHC)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 184M $3.21B -$79.3M $17.45 230
2025 Q2 189M $2.64B +$73.5M $14.00 213
2025 Q1 181M $3.37B +$108M $18.62 202
2024 Q4 176M $1.98B +$95.9M $11.25 169
2024 Q3 166M $1.96B -$14.3M $11.82 135
2024 Q2 168M $1.31B +$30.3M $7.82 114
2024 Q1 160M $793M -$12.7M $4.96 96
2023 Q4 380K $3.27M +$534K $8.61 2
2023 Q3 161M $1.12B +$2.72M $6.94 125
2023 Q2 161M $927M -$43.6K $5.75 136
2023 Q1 160M $1.02B -$29.7M $6.36 128
2022 Q4 162M $1.9B +$60.3M $11.76 141
2022 Q3 156M $1.85B -$85.9M $11.84 145
2022 Q2 156M $1.78B +$22.2M $11.41 88
2022 Q1 154M $1.73B -$11.6M $11.23 85
2021 Q4 152M $2.14B +$59.8M $14.06 93
2021 Q3 149M $2.38B +$14.4M $15.98 61
2021 Q2 148M $3.45B +$63.2M $23.37 56
2021 Q1 146M $3.17B +$3.17B $21.93 51